Loss of local control with prolongation in radiotherapy
- PMID: 1534082
- DOI: 10.1016/0360-3016(92)90768-d
Loss of local control with prolongation in radiotherapy
Abstract
Twelve published clinical results of radical radiotherapy of head and neck cancer have been reviewed, seven of them with fresh multivariate analyses, to determine the magnitude of time factors relating local control to overall time. In all but two of the data sets a significant loss of local control was observed with prolongation. The median rate of loss was 14% in only 1 week, the range 3 to 25%. This corresponds to a median loss of 26% in 2 weeks (5-42%). These results are comparable with other, less detailed information. Whether these significant losses are due to proliferation of tumor cells or to other causes such as physician selection, it is clear that modest prolongation is associated with a lower chance of local control.
Similar articles
-
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.Int J Radiat Oncol Biol Phys. 1994 Apr 30;29(1):153-62. doi: 10.1016/0360-3016(94)90238-0. Int J Radiat Oncol Biol Phys. 1994. PMID: 8175423 Clinical Trial.
-
Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.Cancer J Sci Am. 1996 Nov-Dec;2(6):321-9. Cancer J Sci Am. 1996. PMID: 9166552
-
Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis.BMC Cancer. 2015 Oct 21;15:758. doi: 10.1186/s12885-015-1750-7. BMC Cancer. 2015. PMID: 26490539 Free PMC article.
-
Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.Head Neck. 2015 Jan;37(1):134-50. doi: 10.1002/hed.23542. Epub 2014 Jan 31. Head Neck. 2015. PMID: 24481720 Review.
-
The role of stereotactic body radiotherapy in reirradiation of head and neck cancer recurrence.Crit Rev Oncol Hematol. 2018 Feb;122:194-201. doi: 10.1016/j.critrevonc.2017.12.007. Epub 2017 Dec 15. Crit Rev Oncol Hematol. 2018. PMID: 29373181 Review.
Cited by
-
Hypoxia and anaemia in patients with cancer of the uterine cervix.Clin Transl Oncol. 2005 Sep;7(8):323-31. doi: 10.1007/BF02716547. Clin Transl Oncol. 2005. PMID: 16185600 Review.
-
Three-week hypofractionated radiotherapy in early glottic cancer-a single institution retrospective study.Ecancermedicalscience. 2022 May 4;16:1381. doi: 10.3332/ecancer.2022.1381. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35919227 Free PMC article.
-
The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy.Eur Arch Otorhinolaryngol. 2008 Oct;265(10):1245-55. doi: 10.1007/s00405-008-0664-2. Epub 2008 Apr 5. Eur Arch Otorhinolaryngol. 2008. PMID: 18392632
-
Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore.Radiother Oncol. 2020 Jul;148:189-193. doi: 10.1016/j.radonc.2020.03.030. Epub 2020 Mar 31. Radiother Oncol. 2020. PMID: 32342873 Free PMC article.
-
Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study.Radiat Oncol. 2013 May 2;8:108. doi: 10.1186/1748-717X-8-108. Radiat Oncol. 2013. PMID: 23638721 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical